Trial completion marks an important milestone in the development of the next generation, embolic protection platform MINNEAPOLIS, Nov. 21, 2024 /PRNewswire/ -- Cardiovascular medical device company, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results